glp 1 agonist therapy GLP-1 Receptor Agonists: The New Wave in Diabetes Management What Is GLP-1 Therapy and
Description
A few GLP-1 agonists currently in phase 3 trials are higher-dose injectable semaglutide 7.2 mg (Novo Nordisk), oral semaglutide 50 mg (Novo Nordisk) and orforglipron (Eli Lilly)
Market Outlook and Strategic Insights The obesity and weight loss treatment landscape will undergo substantial transformation in the coming years
Macular Edema: Poorly controlled diabetes can cause fluid leakage into the macula (the central part of the retina responsible for detailed vision)
Nat Rev Endocrinol (2019) 15:28898
Glucagon like peptide-1 receptor (GLP-1R) is a member of the B family of G protein-coupled receptors
